Condition 1: HIV. Condition 2: Hepatitis B. Human immunodeficiency virus [HIV] disease Acute hepatitis B
Conditions
Interventions
Intervention 1: Control: To control group, a training session based on the protocol Ministry of Health to prevent HIV infection in the mother and child will be held after filling out the questionnaire
Prevention
Control: To control group, a training session based on the protocol Ministry of Health to prevent HIV infection in the mother and child will be held after filling out the questionnaire.
In this intervention peers education is the most important part of education. Researcher make a test, based on check list of intervention session and each peer who be able to get satisfaction score wi
Sponsors
Research Deputy school of Nursing and Midwifery of Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria:Age over 18 years;When filling out the questionnaire and participate in the class have the ability to answer and dialogue;Having at least degree of knowledge;substance use at least for 3 months; sexually active;lack of HIV infection.exclusion criteria: do not participate in training class for more than one session;Happening unexpected events
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-esteem. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Rosenberg Self-esteem Questionnaire.;Perceived Vulnerability to HIV. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Vulnerability to HIV Questionnaire.;Perceived Vulnerability to Hepatits b. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Vulnerability to Hepatitis B Questionnaire.;Performance. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Condom use. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;HIV test. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;HBV TEST. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;Type of sex. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;Number of partner. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;Number of save sex. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoheila Ahmadi
School of Nursing & Midwifery Iran University of Medical Sciences
Outcome results
None listed